Issued Patents All Time
Showing 1–11 of 11 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12319700 | Monohydrate potassium salt of a thienopyridone derivative and its preparation process | Marc Lanz, DENIZ ARICAN, Anthony Cornelius O'Sullivan, Sophie Hallakou-Bozec, Laure Françoise Valérie Navarre | 2025-06-03 |
| 12310949 | Use of a thienopyridone derivative in the treatment of autosomal dominant polycystic kidney disease (ADPKD) | Pascale Fouqueray, Sophie Hallakou-Bozec | 2025-05-27 |
| 12036226 | Methods of treating subjects having diabetes with chronic kidney disease | Bill Symonds, Steve Piscitelli, Karen Segal, Ruby Holder, Sophie Bozec +6 more | 2024-07-16 |
| 11850238 | Use of a thienopyridone derivative in the treatment of adrenoleukodystrophy or adrenomyeloneuropathy | Pascale Fouqueray, Sophie Hallakou-Bozec | 2023-12-26 |
| 11813362 | Film-coated tablet comprising a triazine derivative for use in the treatment of diabetes | Maxime Laugier | 2023-11-14 |
| 11767317 | Methods of synthesizing enantiopure deuterium-enriched pioglitazone | Laure Françoise Valérie Navarre, Vincent Jacques | 2023-09-26 |
| 11319313 | Crystalline forms of deuterium-enriched pioglitazone | Laure Françoise Valérie Navarre, Emeline Gardette, Sheila DeWitt, Vincent Jacques | 2022-05-03 |
| 11266652 | Methods of treating subjects having diabetes with chronic kidney disease | Bill Symonds, Steve Piscitelli, Karen Segal, Ruby Holder, Sophie Bozec +6 more | 2022-03-08 |
| 9365584 | Thieno [2,3-B] pyridinedione activators of AMPK and therapeutic uses thereof | Daniel Cravo, Sophie Hallakou-Bozec, Franck Lepifre, Laurent Faveriel, Jean-Denis Durand +1 more | 2016-06-14 |
| 9284329 | Thienopyridone derivatives useful as activators of AMPK | Daniel Cravo, Sophie Hallakou-Bozec, Franck Lepifre, Laurent Faveriel, Jean-Denis Durand +1 more | 2016-03-15 |
| 9271984 | Treatment of type 1 diabetes | Pascale Fouqueray, Daniel Cravo, Sophie Hallakou-Bozec | 2016-03-01 |